Back to archive CA030-001: A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors Principal investigator: Micaela Hernberg Trial site: HUS Comprehensive Cancer Center Link to the ClinicalTrials.gov study website
